Non-Current Assets
PP&E (Net)
Medtronic PP&E (Net) increased by 0.2% to $7.18B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.9%, from $6.59B to $7.18B. Over 4 years (FY 2021 to FY 2025), PP&E (Net) shows an upward trend with a 7.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ3 2026Feb 24, 2026
How to read this metric
A steady increase indicates ongoing investment in production capacity, while a decline may suggest aging assets or a shift toward outsourcing.
Detailed definition
This represents the net book value of tangible long-lived assets, such as manufacturing facilities, laboratories, and sp...
Peer comparison
Medical device companies are capital-intensive, requiring significant investment in high-precision manufacturing facilities.
Metric ID:
property_plant_equipment_netHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.22B | $5.16B | $5.19B | $5.25B | $5.41B | $5.28B | $5.3B | $5.44B | $5.57B | $5.67B | $5.74B | $5.84B | $6.13B | $6.28B | $6.44B | $6.59B | $6.84B | $7.01B | $7.16B | $7.18B |
| QoQ Change | — | -1.1% | +0.5% | +1.2% | +3.1% | -2.4% | +0.3% | +2.6% | +2.4% | +1.7% | +1.2% | +1.8% | +5.0% | +2.5% | +2.5% | +2.4% | +3.7% | +2.5% | +2.3% | +0.2% |
| YoY Change | — | — | — | — | +3.7% | +2.3% | +2.1% | +3.5% | +2.9% | +7.3% | +8.2% | +7.4% | +10.1% | +10.9% | +12.3% | +12.9% | +11.5% | +11.5% | +11.3% | +8.9% |
Range$5.16B – $7.18B
CAGR+6.9%
Avg YoY Growth+7.9%
Median YoY Growth+8.6%
Current Streak14 quarters growth
Geographic Breakdown — UNITED STATES
| Segment | Q4 '24 |
|---|---|
| UNITED STATES | $4.59B |
| Ireland | $252M |
| Total | $6.13B |
Geographic Breakdown — Total other countries, excluding Ireland
| Segment | Q4 '24 | Q4 '25 |
|---|---|---|
| Rest of world | $1.29B | $1.41B |
| Total other countries, excluding Ireland | $5.88B | — |
| Total | $6.13B | $6.84B |
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is Medtronic's pp&e (net)?
- Medtronic (MDT) reported pp&e (net) of $7.18B in Q4 2025.
- How has Medtronic's pp&e (net) changed year-over-year?
- Medtronic's pp&e (net) increased by 8.9% year-over-year, from $6.59B to $7.18B.
- What is the long-term trend for Medtronic's pp&e (net)?
- Over 4 years (2021 to 2025), Medtronic's pp&e (net) has grown at a 7.0% compound annual growth rate (CAGR), from $5.22B to $6.84B.
- What does pp&e (net) mean?
- The net value of the company's physical assets like factories and equipment after accounting for wear and tear.